If hyperglycemia persists despite the use of metformin, it may be appropriate to incorporate sodium-glucose cotransporter-2 (SGLT2) inhibitors into the treatment regimen, or other potentially effective pharmacologic options such as sulfonylureas or insulin should be considered [8]. The gene discussed is SLC5A2; the disease is Hyperglycemia.